Oruka Therapeutics (ORKA) Misses Q1 EPS by 48c
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics (NASDAQ: ORKA) reported Q1 EPS of ($0.48).
For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)
- Piper Sandler Starts Dave Inc (DAVE) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
